Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-09-25
1994-01-04
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
A61K 3700
Patent
active
052760170
ABSTRACT:
Therapeutic and diagnostic applications by the manipulation of a unique protein produced by trophoblasts and defined by the monoclonal antibody FDC-6 are provided by this invention.
REFERENCES:
patent: 4894326 (1990-01-01), Matsuura et al.
Feinberg et al., "Abstract", vol. 12, 1991, p. 387.
Kliman et al., "Purification, characterization and in vitro differentiation of cytotrophoblasts from human term placentae," Endocrinol. 118: 1567-1582 (1986).
Matsuura et al. (J. Biol. Chem. 263, 3314-22 (1988).
Kao et al., Dev Biol. 130:693-702 (1988).
Stroop et al., "Localization of herpes simplex virus in the trigeminal and olfactory systems in the mouse central nervous system during acute and latent infections by in situ hybridization," Lab. Invest. 51:27-38 (1984).
Kalofonos et al., "Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase," J Nucl Med 30:1636-45 (1989).
A. Gleicher, N, el RA. (1988) "The reproductive autoimmune failure syndrome," Am J Obstet Gynecol 159:223-7.
Helmer et al. "Intrauterine infusion of highly enriched bovine trophoblast protein-1 complex exerts an antiluteolytic effect to extend corpus luteum life span in cyclic cattle," J Reprod Fertil 87:89-101 (1989).
Jones, R. C. "Blastocyst attachment in the ovariectomized rat treated with an intrauterine injection of luteinizing hormone-releasing hormone (LRH)," Acta Endocrinol (Copenh) 103:266-8 (1983).
Ekman et al., "Intracervical instillation of PGE2-gel in patients with missed abortion or intrauterine fetal death," Arch Gynecol 233:241-5 (1983).
Zhu et al. "The effect of intrauterine devices, the stainless steel ring, the copper T220, and releasing levonorgestrel, on the bleeding profile and the morphological structure of the human endometrium--a comparative study of three IUDs. A morphometric study of 96 cases," Contraception 40:425-38 (1989).
Botelho et al. "cAMP analog antagonists of cAMP action," Methods Emzymol 159: 159-72 (1988).
Botelho et al. in "Inhibition of cAMP-dependent protein kinase by adenosine cyclic 3'-, 5'-phosphorodithioate, a second cAMP antagonist," J Biol Chem 263:5301-5 (1988).
Miyagi et al., "Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure," J Cardiovasc Pharmacol 15:138-43 (1990).
Berg et al., "Effects of different phsophodiesterase-inhibiting drugs on human pregnant myometrium: an in vitro study," Arch Int Pharmacodyn Ther 290:288-92 (1987).
Tortora et al., "An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects," Proc Natl Acad Sci USA 87:705-8 (1990).
Frydman et al., "Phase I clinical trial of monoclonal anti-human chorionic gonadotropin antibody in women with an ectopic pregnancy," Fertil Steril 52:734-8 (1989).
Skarp et al., "Use of a human monoclonal anti-cytomegalovirus antibody for the treatment of severe cytomegalovirus after renal transplantation," Transplant Proc 22:234 (1990).
Ehrlich, et al., "Human and primate monoclonal antibodies for in vivo therapy," Clin. Chem. 34/9:1681-1688 (1988).
Liu et al., "Contraception in mares heteroimmunized with pig zonae pellucidae," J Reprod Fertil 85:19-29 (1989).
A. Gonzalez, et al., "Immunological approaches to contraception in dogs," J. Reprod. Fert., Suppl. 39: 189-198 (1989).
Feinman et al., "8-Bromo-3'5' stimulates the endocrine activity of human cytotrophoblasts in culture," J. Clin end Metab 63:1211-1217 (1986).
Matsuura et al., "The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma," Proc Natl Acad Sci USA 82:6517-21 (1985).
I. Kharat, et al., "Analysis of menstrual records of women immunized with anti-hCG vaccines inducing antibodies partially cross-reactive with hLH," Contraception, vol. 41, No. 3:293-299 (1990).
E. Engvall, et al., "Binding of soluble form of fibroblast surface protein, fibronectin, to collagen," Int. J. Cancer, 20:1-5 (1977).
Feinberg Ronald F.
Kliman Harvey J.
Larson Kristin K.
Robinson Douglas W.
Trustees of the University of Pennsylvania
LandOfFree
Therapeutic and diagnostic applications of tropho-uteronectin (T does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic and diagnostic applications of tropho-uteronectin (T, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic and diagnostic applications of tropho-uteronectin (T will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-307168